Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Recent findings in breast cancer described by A. Brufsky and colleagues
July 17th, 2008
"The interim ( 12-month) results of two similarly designed, ongoing studies (the Zometa (R)- Femara (R) Adjuvant Synergy Trials [Z-FAST and ZO-FAST]) suggest that zoledronic acid ( 4 mg intravenously every 6 months) when initiated with adjuvant letrozole increases bone mineral density ( BMD) of the lumbar spine (LS) in postmenopausal women with early-stage breast cancer compared with patients who receive zoledronic acid only when bone loss became clinically significant or a fragility fracture occurred. An integrated analysis was performed to maximize the value of the large pool of data from the two studies in answering clinically relevant questions," researchers in the United States...
Source: Women's Health Weekly (2008-07-17)
|
|
Advertisement |
|
|
|
